Device Week, Feb. 15, 2018 – Neurostim Advances And Innovation Investments
Executive Summary
In this episode of Device Week, Medtech Insight’s Reed Miller chats to Marion Webb about the most interesting presentations by the key spinal cord stimulation players at this year’s NANS meeting in Las Vegas, and also finds out from Tina Tan how the venture financing climate has been for start-ups in January.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.